Graft Type and Outcomes After ACL Reconstruction in Female Athletes (LCA-WOMEN)

July 19, 2026 updated by: Luis Gutiérrez Sánchez, Universidad Católica San Antonio de Murcia

Influence of Graft Type on Functional and Neuromuscular Outcomes After Anterior Cruciate Ligament Reconstruction in Female Athletes: A Prospective Multicenter Cohort Study

This prospective multicenter cohort study aims to compare clinical and functional outcomes between hamstring tendon and quadriceps tendon autografts in anterior cruciate ligament (ACL) reconstruction in female athletes. Participants will be followed for two years after surgery to evaluate graft failure rates, return to sport, knee stability, and patient-reported outcomes.

Study Overview

Detailed Description

Anterior cruciate ligament injuries are particularly prevalent in female athletes and represent a major challenge in sports medicine. The choice of graft type in ACL reconstruction may influence clinical outcomes, yet evidence specifically in female populations remains limited. This study prospectively enrolls female athletes undergoing ACL reconstruction with either hamstring tendon or quadriceps tendon autograft across multiple centers in Spain. Primary outcome is graft failure rate at 24 months. Secondary outcomes include return to sport rate, IKDC score, KOOS, Lysholm scale, limb symmetry index, and re-injury rate. Data will be collected preoperatively and at 6, 12, and 24 months postoperatively.

Study Type

Observational

Enrollment (Estimated)

82

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Female athletes aged 16 to 35 years undergoing primary ACL reconstruction with either hamstring tendon or quadriceps tendon autograft across multiple sports medicine centers in Spain.

Description

Inclusion Criteria:

  • Female patients aged 16 to 35 years with skeletal maturity
  • Active athlete: minimum two training sessions per week during the six months prior to injury in pivoting sports
  • Confirmed complete ACL rupture by MRI and clinical examination
  • Primary ACL reconstruction (first ligament surgery on the index knee)
  • Time from injury to surgery no longer than 6 months
  • Signed informed consent

Exclusion Criteria:

  • Previous ligament surgery on either knee
  • Multiligament injury: simultaneous PCL, grade III MCL or LCL injury
  • Neuromuscular, rheumatological or systemic pathology interfering with rehabilitation or functional assessments
  • Pre-existing radiological osteoarthritis grade Kellgren-Lawrence ≥2 in the index knee
  • Inability to complete 24-month follow-up protocol
  • Pregnancy at inclusion or during follow-up period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Hamstring tendon autograft
Female athletes undergoing ACL reconstruction with hamstring tendon autograft
ACL reconstruction using ipsilateral hamstring tendon autograft (semitendinosus and gracilis tendons) with arthroscopic technique
Quadriceps tendon autograft
Female athletes undergoing ACL reconstruction with quadriceps tendon autograft
ACL reconstruction using ipsilateral quadriceps tendon autograft with arthroscopic technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Graft failure rate
Time Frame: 24 months after surgery
Proportion of patients requiring revision ACL reconstruction or presenting with objetive graft rupture confirmed by MRI or arthroscopy
24 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
return to sport rate
Time Frame: 12 and 24 months after surgery
proportion of athletes who returned to their pre-injury sport level, assessed by athlete and surgeon
12 and 24 months after surgery
IKDC Subjective knee Evaluation Form
Time Frame: 6, 12 and 24 months after surgery
Patient-reported outcomes measure assessing knee symptoms, function and sports activity.
6, 12 and 24 months after surgery
KOOS (Knee Injury and Osteoarthritis outcome Score)
Time Frame: 6, 12 and 24 months after surgery
Patient-reported outcome measure assessing pain, symptoms, function in daily living, function in sport and recreation, and knee-related quality of life
6, 12 and 24 months after surgery
Lysholm Knee Scoring Scale
Time Frame: 6, 12 and 24 months after surgery
Clinician-reported outcome measure assessing knee function including pain, instability, locking, swelling, stair climbing, squatting and limp
6, 12 and 24 months after surgery
Limb Symetry Index (LSI)
Time Frame: 6, 12 and 24 months after surgery
Assessed vy isokinetic dynamometry and single-leg hop tests to evaluate quadriceps and hamstring strength symmetry between limbs
6, 12 and 24 months after surgery
Re-injury rate
Time Frame: 24 months after surgery
Proportion of patients sustaining a new ipsilateral or contralateral ACL injury during the follow-up period.
24 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

August 1, 2028

Study Completion (Estimated)

December 1, 2028

Study Registration Dates

First Submitted

July 19, 2026

First Submitted That Met QC Criteria

July 19, 2026

First Posted (Actual)

July 23, 2026

Study Record Updates

Last Update Posted (Actual)

July 23, 2026

Last Update Submitted That Met QC Criteria

July 19, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • IMED-LCA-HT-QT-2026
  • CE042605 (Other Identifier: Comite de Etica de la UCAM)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Cruciate Ligament Injuries

Clinical Trials on Hamstring tendon autograft ACL reconstruction

Subscribe